期刊文献+

霉酚酸酯联合激素治疗成人狼疮性肾炎的疗效观察 被引量:5

Clinical Efficacy of Mycophenolate Mofetil Combined with Hormone Treatment on Adults with Lupus Nephritis
下载PDF
导出
摘要 目的探讨霉酚酸酯(MMF)联合激素治疗成人狼疮性肾炎(LN)的临床疗效及其安全性。方法选取自2006年6月至2011年10月仙桃市第一人民医院收治的26例LN患者,给予MMF联合糖皮质激素进行规范治疗。糖皮质激素(20~40 mg/d),逐渐减量,MMF初始剂量1.5 g/d,3个月后减至维持剂量0.75~1.0 g/d继续治疗,治疗时间3~24个月。结果 MMF联合糖皮质激素治疗后24 h尿蛋白下降,血清白蛋白升高,血清自身抗体显著减少,补体C3、C4升高;26例患者重复活检,肾小球活动性病变显著减轻。MMF治疗的不良反应较少,偶有消化道反应、感染及带状疱疹发生等。结论 MMF对于成人各型LN,尤其是经传统治疗无效者,临床疗效显著、安全,且长期使用不良反应少。 Objective To explore the efficacy and safety of mycophenolate mofetil(MMF) combined with hormone treatment of adults with lupus nephritis.Methods From Jun.2006 to Oct.2010,26 patients with confirmed lupus nephritis were treated by glucocorticoid and MMF therapy in the First People's Hospital of Xiantao.Glucocorticoids(20-40 mg / d),gradual reduction of the initial dose,MMF was 1.5 g / d,three months later reduced to a maintenance dose of 0.75 to 1.0 g / d to continue the treatment,treatment duration was 3 to 24 months.Results After treatment,24 hours urinary protein excretion decreased,serum albumin increased,serum autoimmune antibodies significantly reduced,complement C3 and C4 increased;26 cases of repeated biopsy,the glomerular active lesions were significantly reduced.The side effects of MMF were less,with occasional gastrointestinal reactions,infections and herpes zoster observed.Conclusion MMF can be used in lupus nephritis of adults,especially in patients refractory to other conventional treatment regimes,with distinct clinical curative effect,good safety and less side effects for the long-term application.
出处 《医学综述》 2013年第13期2427-2429,共3页 Medical Recapitulate
关键词 狼疮性肾炎 霉酚酸酯 糖皮质激素 治疗 Lupus nephritis Mycophenolate mofetil Glucocorticoid Therapy
  • 相关文献

参考文献6

  • 1Buhaescu I,Covic A,Deray G.Treatment of proliferative lupusnephritis—a critical approach[J].Semin Arthritis Rheum,2007,36(4):224-237.
  • 2Flanc RS,Roberts MA,Strippoli GF,et al.Treatment for lupusnephritis[J].Cochrane Database Syst Rev,2004,(1):CD002922.
  • 3刘志红,黎磊石.霉酚酸酯在重症狼疮性肾炎中的应用[J].肾脏病与透析肾移植杂志,2002,11(6):537-538. 被引量:19
  • 4欧三桃,钟利春,杜新,黄颂敏,刘琦,赵安菊,陈泽君,刁骧(审校).霉酚酸酯治疗增生性狼疮肾炎的系统评价[J].中国循证医学杂志,2006,6(10):712-720. 被引量:12
  • 5Dooley MA.Mycophenolate mofetil:what role in the treatment oflupus?[J].Lupus,2006,15(3):179-182.
  • 6Bijl M,Horst G,Bootsma H,et al.Mycophenolate mofetil prevents aclinical relapse in patients with systemic lupus erythematosus at risk[J].Ann Rheum Dis,2003,62(6):534-539.

二级参考文献16

  • 1朱彬,周振安,刘子栋,王小平,任万军.霉酚酸酯与环磷酰胺治疗Ⅳ型狼疮性肾炎的疗效比较[J].山东大学学报(医学版),2003,41(6):692-694. 被引量:11
  • 2Boumpas DT, Austin HA III, Vaughn EM, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.Lancet, 1992; 340: 741-745.
  • 3Dooley MA, Cosio FG, Nachman PH, et al. Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephml,1999;10(4): 833 839.
  • 4Tan EM, Cohen AS, Fries JF, et al. The1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum,1982; 25:1271 1277.
  • 5Egger M, Smith GD, Altman DG. Systematic Reviews in Heath Care. London: Tavistock Square, Second edition, 2001.73-78.
  • 6Jadad AR ,Moore A ,Carrol D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary. Control Clin Trials, 1996; 17: 1-12.
  • 7Cochrane Reviewer's Handbook 4.2.2. The Cochrane Collaboration,2000.
  • 8Schulz KF, Chalmers I, Hayes RJ. Empirical evidence of bias.JAMA, 1995; 273: 408-412.
  • 9Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med,2000; 343(16): 1156-1162.
  • 10Chan TM, Tse KC, Tang CS, et al. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol,2005; 16(4): 1076-1084.

共引文献29

同被引文献32

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部